- Research Paper
- Open Access
Extracts of Rehmanniae radix, Ginseng radix and Scutellariae radix improve glucose-stimulated insulin secretion and β-cell proliferation through IRS2 induction
© Springer-Verlag 2007
- Published: 20 November 2007
Recent studies have revealed that β-cell dysfunction is an important factor in developing type 2 diabetes. β-cell dysfunction is related to impairment of the insulin/IGF-1 signaling cascade through insulin receptor substrate-2 (IRS2). The induction of IRS2 in β-cells plays an important role in potentiating β-cell function and mass. In this study, we investigated whether herbs used for treating diabetes in Chinese medicine—Galla rhois, Rehmanniae radix, Machilus bark, Ginseng radix, Polygonatum radix, and Scutellariae radix—improved IRS2 induction in rat islets, glucose-stimulated insulin secretion and β-cell survival. R. radix, Ginseng radix and S. radix significantly enhanced glucose-stimulated insulin secretion compared to the control, i.e., by 49, 67 and 58%, respectively. These herbs induced the expression of IRS2, pancreas duodenum homeobox-1 (PDX-1), and glucokinase. The increased level of glucokinase could explain the enhancement of glucose-stimulated insulin secretion with these extracts. Increased PDX-1 expression was associated with β-cell proliferation, which was consistent with the cell viability assay. In conclusion, R. radix, Ginseng radix and S. radix had an insulinotropic action similar to that of exendin-4.
- Rat islets
- Insulin secretion
- β-cell proliferation
Insulin resistance and β-cell dysfunction lead to type 2 diabetes . Insulin resistance and diabetes increase the incidence of metabolic disorders such as diabetes, hypertension, dyslipidemia, obesity, stroke, retinopathy, myocardial infarction and neurodegeneration . β-Cell dysfunction, which is associated with modulation of β-cell mass, is an important factor in developing type 2 diabetes [5, 16]. The dysfunction is related to impairment of the insulin/IGF-1 signaling cascade [8, 18]. Insulin receptor substrate 2 (IRS2) is the primary and predominate protein delivering insulin/insulin like growth factor-1 (IGF-1) signaling in pancreatic β-cells . The pleckstrin homology (PH) and phosphotyrosine-binding (PTB) domains of IRS2 bind to phosphorylated insulin receptor upon binding of insulin or IGF-1 to their receptors. Phosphorylated IRS2 protein binds to and activates phosphatidylinositol 3 (PI3) kinase. PI3 kinase sends signals into several different pathways , resulting in increased cellular growth, anti-apoptosis and protein synthesis in β-cells. Thus, IRS2 is an important protein in β-cell growth and survival.
Most studies aimed at determining the role of IRS2 have been performed in gene-manipulated mice [8, 18]. Mice overexpressing IRS2 in β-cells were found to improve glucose homeostasis by enhancing glucose-stimulated insulin secretion . However, this cannot be applied to physiological conditions. The question was raised whether IRS2 induction occurs under physiological conditions. White  found evidence that a cAMP responding element (CRE) site exits upstream of the IRS2 coding region in humans and mice . Several studies have shown that CRE binding protein (CREB) activation increases IRS2 expression [10, 15]. Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist originally extracted from lizard venom, increased IRS2 levels in islets through elevated intracellular cAMP levels . GLP-1/exendin-4 is known to enhance glucose-stimulated insulin secretion and to increase β-cell transcription factors, such as pancreas duodenum homeobox-1 (PDX-1), to promote β-cell growth and survival [4, 15]. These actions of exendin-4 were associated with IRS2 induction. Thus, IRS2 pathways play an important role in β-cell expansion, which is required to elevate insulin secretion to overcome hyperglycemia. In this study, we investigated whether six herbs used for treating diabetes in Chinese medicine improved IRS2 induction in rat islets, glucose-stimulated insulin secretion, and β-cell survival. The herbs used were Galla rhois, Rehmanniae radix (Rehmannia glutinosa LIBOSCHITZ var. purpurea MAKING), Machilus bark (Machilus thynbergii SIEBOLD et ZUCCARINI), Polygonatum radix (Polygonatum odoratum Miller Druce), Ginseng radix (Panax ginseng C.A. MEYER), and Scutellariae radix (Scutellariae baicalensis GEORGI).
Galla rhois, Rehmannia radix, Machilus bark, Ginseng radix, Polygonatum radix, and Scutellariae radix were each extracted with 70% ethanol at 50°C for 12 h. The extracts were filtered through a 0.4 μm filter, and concentrated by vacuum evaporation and lysophilization. The powder was dissolved in sterile dimethyl sulfoxide (DMSO; Sigma, St. Louis, MO) to 1 mg/ml, and then further diluted with sterile phosphate buffered saline or medium to the required concentration.
Glucose-stimulated insulin secretion in islets
Pancreatic islets from male rats were isolated by collagenase digestion as previously described [8, 15], and then incubated for 24 h in high glucose Dulbecco’s modified Eagles medium (DMEM) containing 10% (v/v) heat-inactivated fetal bovine serum, 50 μM β-mercaptoethanol, penicillin and streptomycin at 37°C in a humidified atmosphere with 5% CO2 to allow recovery from the isolation process and to eliminate acinar cells. Twenty islets were pre-incubated with low glucose DMEM containing 5 mg/ml bovine serum albumin (BSA) for 16 h in order to recover condition following the digestion process. The islets were treated with the vehicle (DMSO) or designated concentrations of each herb extract in low (2 mM) or high glucose (20 mM) Krebs-Ringer buffer containing 20 mM Hepes (pH 7.4) and 5 mg/ml BSA for 30 min. Insulin concentrations for each medium were measured from the low and high glucose media using a radioimmunoassay kit (Linco Research, St. Charles, MO). Exendin-4 (2.5 nM) was used as a positive control. Cell viability was measured with a WST-1 colorimetric assay kit (Roche, Basel, Switzerland) at 6, 12 and 36 h as each herb extract was treated for 36 h. These experiments were repeated four times.
- IRS2 forward::
- IRS2 reverse::
- PDX-1 forward::
- PDX-1 reverse::
- Glucokinase forward::
- Glucokinase reverse::
- Cyclophilin forward::
- Cyclophilin reverse::
All results are expressed as mean ± SD. Statistical analysis was performed using the SAS program. Two sample t-test was carried out to determine the significant difference between the control (DMSO) and each herb extract. Results of P < 0.05 were considered statistically significant.
Glucose-stimulated insulin secretion in islets
Treatment with exendin-4, a GLP-1 agonist, enhances glucose-stimulated insulin secretion in rodents and humans. Human studies have shown that extended administration of GLP-1 not only augments glucose-stimulated insulin secretion, but also shifts the dynamics of the insulin response to earlier release in both diabetic and non-diabetic humans [2, 9]. The mechanism was revealed as acting directly through the cAMP/protein kinase A (PKA) pathway to enhance and sensitize β-cells to glucose-stimulated insulin secretion. Activated PKA may close KATP channels, and activate Ca2+ channels and exocytosis of insulin containing granules . GLP-1 also increases insulin secretion in a calcium- and PKA-independent manner by mobilizing secretory vesicles to enter the readily releasable pool . R. radix, Ginseng radix and S. radix may enhance glucose-stimulated insulin secretion through cAMP/PKA-dependent and/or -independent pathways. No studies have examined whether R. radix, Ginseng radix, S. radix or their components modulate insulin secretion through the cAMP/PKA pathway in islets. However, accumulating evidence indicates that ginsenosides—major components of ginseng—modulate the release of neurotransmitters in neuronal cells through the cAMP/PKA pathway . Ginsenoside Rb1 promotes neurotransmitter release by increasing the phosphorylation of synapsins through PKA-pathway-activated neurotransmission . In addition, ginsenoside Rb1 and the lipophilic fraction of ginseng increase intracellular cAMP in liver and platelets, respectively [13, 14]. Baicalein, a major flavonoid derived from S. radix, was also found to potentiate Ca2+-mediated Cl− secretion through a signaling pathway involving cAMP and protein kinase A in the apical membrane of intestinal epithelial cells . Thus, R. radix, Ginseng radix and S. radix may enhance glucose-stimulated insulin secretion in β-cells through a cAMP-mediated pathway.
mRNA levels of IRS2, PDX-1, and glucokinase islets
In conclusion, extracts of Rehmanniae radix, Ginseng radix and Scutellariae radix enhanced glucose-stimulated insulin secretion by improving glucose sensing through increased glucokinase expression. In addition, they increased IRS2 induction to elevate β-cell proliferation through the induction of PDX-1 via potentiating insulin/IGF-1 signaling. Thus, these extracts contain candidates for an insulinotropic agent like exendin-4.
This work was supported by a grant from the Korea Research Foundation in Korea (KRF-2005-041-C00510); BioFood Research Program, Ministry of Science and Technology.
- Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139PubMedView ArticleGoogle Scholar
- Alarcon C, Wicksteed B, Rhodes CJ (2006) Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level. Diabetologia 49:2920–2929PubMedView ArticleGoogle Scholar
- Beguin P, Nagashima K, Gonoi T, Shibasaki T, Takahashi K, Kashima Y, Ozaki N, Geering K, Iwanaga T, Seino S (2001) Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem. Nature 411:701–706PubMedView ArticleGoogle Scholar
- Buteau J, Roduit R, Susini S, Prentki M (1999) Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia 42:856–864PubMedView ArticleGoogle Scholar
- Chiasson JL, Rabasa-Lhoret R (2004) Prevention of type 2 diabetes: insulin resistance and beta-cell function. Diabetes 53:S34–S38PubMedView ArticleGoogle Scholar
- Doyle ME, Egan JM (2003) Pharmacological agents that directly modulate insulin secretion. Pharmacol Rev 55:105–131PubMedView ArticleGoogle Scholar
- Efanov AM, Barrett DG, Brenner MB, Briggs SL, Delaunois A, Durbin JD, Giese U, Guo H, Radloff M, Gil GS, Sewing S, Wang Y, Weichert A, Zaliani A, Gromada J (2005) A novel glucokinase activator modulates pancreatic islet and hepatocyte function. Endocrinology 146:3696–3701PubMedView ArticleGoogle Scholar
- Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, Schubert M, Fisher TL, Dow MA, Leshan R, Zakaria M, Mossa-Basha M, White MF (2003) Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 112:1521–1532PubMedView ArticleGoogle Scholar
- Iltz JL, Baker DE, Setter SM, Campbell RK (2006) Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus. Clin Ther 28:652–665PubMedView ArticleGoogle Scholar
- Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White MF, Montminy M (2003) cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17:1575–1580PubMedView ArticleGoogle Scholar
- Kulkarni RN, Jhala US, Winnay JN, Krajewski S, Montminy M, Kahn CR (2004) PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 114:828–836PubMedView ArticleGoogle Scholar
- Otani K, Kulkarni RN, Baldwin AC, Krutzfeldt J, Ueki K, Stoffel M, Kahn CR, Polonsky KS (2004) Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am J Physiol Endocrinol Metab 286:E41–E49PubMedView ArticleGoogle Scholar
- Park HJ, Lee JH, Song YB, Park KH (1996) Effects of dietary supplementation of lipophilic fraction from Panax ginseng on cGMP and cAMP in rat platelets and on blood coagulation. Biol Pharm Bull 19:1434–1439PubMedGoogle Scholar
- Park KH, Shin HJ, Song YB, Hyun HC, Cho HJ, Ham HS, Yoo YB, Ko YC, Jun WT, Park HJ (2002) Possible role of ginsenoside Rb1 on regulation of rat liver triglycerides. Biol Pharm Bull 25:457–460PubMedView ArticleGoogle Scholar
- Park S, Dong X, Fisher TL, Dunn SL, Omer AK, Weir G, White MF (2006) Exendin-4 promotes IRS2 signaling to mediate pancreatic beta-cell growth and function. J Biol Chem 281:1159–1168PubMedView ArticleGoogle Scholar
- Weir GC, Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53:S16–S21PubMedView ArticleGoogle Scholar
- White MF (1998) The IRS-signaling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182:3–11PubMedView ArticleGoogle Scholar
- Wither DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904View ArticleGoogle Scholar
- Xue JF, Liu ZJ, Hu JF, Chen H, Zhang JT, Chen NH (2006) Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway. Brain Res 1106:91–98PubMedView ArticleGoogle Scholar
- Yue GG, Yip TW, Huang Y, Ko WH (2004) Cellular mechanism for potentiation of Ca2+-mediated Cl− secretion by the flavonoid baicalein in intestinal epithelia. J Biol Chem 279:39310–39316PubMedView ArticleGoogle Scholar